Daidzein, a major isoflavone from soybean, have been shown to lower IL-6 levels in a model of obesity induced neurodegeneration consisting of human fetal hypothalamic gonadotropin-releasing hormone neurons treated with palmitic acid (166). Here, IL6 is linked to obesity disorder.